VACCINE INSIGHTS

September 2022 Issue

Volume 1 Issue 4

Vaccine Insights Volume 1 Issue 4

Featuring

Issue Spotlight: mRNA: harnessing the benefits, addressing the challenges
Other articles
Webinar

SPOTLIGHT

mRNA: harnessing the benefits, addressing the challenges
Norbert Pardi
Guest Editor:
Norbert Pardi, Assistant Professor at University of Pennsylvania

Expert Insight

A blueprint for quality by digital design to support rapid RNA vaccine process development, manufacturing & supply

A blueprint for quality by digital design to support rapid RNA vaccine process development, manufacturing & supply

S Daniel, Z Kis, C Kontoravdi et al.
22 September 2022
Read

Innovator Insight

Discovery to delivery in 100 days: RNA therapeutics & their role in future pandemic preparedness

Discovery to delivery in 100 days: RNA therapeutics & their role in future pandemic preparedness

Tracy Humphries
10 November 2022
Read

Commentary

mRNA Vaccines: a growing and complex IP landscape

mRNA Vaccines: a growing and complex IP landscape

Robert Burrows, Ellen Lambrix
4 September 2022
Read

FastFacts

End-to-end solutions for mRNA development and manufacturing

End-to-end solutions for mRNA development and manufacturing

Susana Domingues-Vallon
21 November 2022
Read

Interview

RNA vaccine production 4.0

RNA vaccine production 4.0

Zoltan Kis
4 September 2022
Read
RNA pioneer Ingmar Hoerr: from entrepreneur to philanthropist

RNA pioneer Ingmar Hoerr: from entrepreneur to philanthropist

Ingmar Hoerr
24 August 2022
Read

Journal articles

Commentary

Healthcare in global crisis: preparations needed during the COVID-19 pandemic

Healthcare in global crisis: preparations needed during the COVID-19 pandemic

B Lall, D Chaudhry, S Shoham et al.
23 September 2022
Read

Podcast

Access to vaccines: how can we leverage technology innovations to achieve greater vaccine equity?

Access to vaccines: how can we leverage technology innovations to achieve greater vaccine equity?

Fatema Kazi
21 September 2022
Listen

Webinars